Positive trend for Swedish medtech exports – “We have new markets that are huge”

In 2024, Swedish exports of pharmaceuticals decreased for the first time in several years. However, the trend for medical technology looks brighter. During a seminar, it was discussed how Swedish life science companies can navigate the changing global situation.

First preterm infants study – a vital step for Neola

After years of developing an advanced lung monitoring system, Neola Medical has received some delightful news: permission to start its first clinical study on preterm born infants.

In search of Marcel Proust's lost health

A great writer, but also a weak person and a hypochondriac. That has been the usual image of Marcel Proust. But the pediatrician and literary scholar Carl Lindgren paints a partly different picture in a new book about the French master's life, health and attitude towards physicians.

The investor: “The major common diseases are hot again”

She has previously been voted Investor of the Year and will now be moderating The Future of Swedish & Danish Life Science congress. We check the temperature of the industry with Nina Rawal from Trill Impact Advisory.

Beta-blockers are often given unnecessarily, a study finds – “This will affect future practice”

Patients who have suffered a minor heart attack do not benefit from beta-blockers, according to a major new study that may change guidelines for cardiac care.

Astra Zeneca’s Sweden CEO: “We have great faith in our portfolio”

It all started with a summer job as an operator at Astra’s chemical factory in Snäckviken, just outside Södertälje. More than three decades and countless different assignments later, Per Alfredsson, born and raised in Södertälje, is CEO of Astra Zeneca Sweden, which employs 7800 people in Södertälje, Stockholm and Gothenburg. “It was a very special feeling to be in charge of the entire organisation,” he says in an interview about his career and potential future blockbusters.

MVA:s CEO: “Our investments should improve people´s everyday lives”

Involuntary infertility and diabetes are two of the areas on the agenda of the Medicon Valley Alliance.

Marie Gårdmark: Big data evidence generation drives change in the EU regulatory system

Rapid developments in technology have led to the possibility for the generation and analysis of vast volumes of data. Will the availability of big data lead to fundamental changes to the regulatory system? In a column Marie Gårdmark, CEO and Senior

Combining two drug delivery strategies to improve bioavailability

Danish researchers hope to increase the bioavailability of low solubility drugs.

Krönika: Collaboration across borders

Opinion: Where do all the cool Swedish life science companies go?

It’s puzzling why Swedish life science companies hardly get a mention alongside Spotify, Skype, Klarna, King, iZettle, and other cool, innovative and successful ‘startups’ founded in Sweden.

Fluorescensmikroskopi förbättras av nytt företag

Två forskare från Uppsala universitet har utvecklat en ny metod för avancerad analys av bilder från fluorescensmikroskopi. Nu startar de företag.

Platelet analysis in whole blood

The new Multiplate analyzer from Triolab uses impedance aggregometry to measure the effects of platelet inhibitors on whole blood.

Double the channels for half the work

The 16-well pipettes from Capp cause less strain for the user when setting up a 384-well plate.

Bioreactor features disposable sensors

The Biostat Cultibag STR line of bioreactors from Sartorius-Stedim features disposable components to reduce risk of contamination.

Ideon - Sweden's oldest science park

Old is not synonymous with boring. Swedens oldest science park Ideon still manages to attract young companies with big ideas. The recipe for success? To continue to invest in further development.

Kjell Strandberg

2009 - ytterligare ett dystert år för Big Pharma.

Cell incubator with built-in microscope

InCu-view live is an incubator from Sanyo for cell or embryo culture with documentation functionality.

Athera signs production partnership

The companys novel cardiovascular product will be manufactured in Germany.